Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins

Parassitologia

Volumn 43, Issue SUPPL. 1, 2001, Pages 1-6

  Brandonis, Olga ^a   Panaro, M A ^a   Sisto, M ^a   Acquafredda, A ^a   Fumarola, L ^a   Leogrande, D ^a   Mitolo, V ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

iNOS; Leishmania; Macrophage; Nitric oxide; Prostaglandin

Indexed keywords

ARGININE; CYTOKINE; DRUG DERIVATIVE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N(G) MONOMETHYLARGININE ACETATE; N(G)-MONOMETHYLARGININE ACETATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL; BIOSYNTHESIS; DOG; HUMAN; LEISHMANIA INFANTUM; MACROPHAGE; METABOLISM; MOUSE; PARASITOLOGY; REVIEW; VISCERAL LEISHMANIASIS;

ANIMALS; ARGININE; CYTOKINES; DINOPROSTONE; DOGS; HUMANS; INTERFERON TYPE II; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDINS;

EID: 0035553059     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bertholet S, Tzeng E, Felley-Bosco E, Mauël J (1999). Expression of the inducible NO synthase in human monocytic U-937 cells allows high output nitric oxide production. J Leukocyte Biol 65:50-58.
2. Bogdan C, Vodovotz Y, Paik J, Xie Q-w, Nathan C (1994). Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukocyte Biol 55:227-233.
3. Bogdan C, Thüring H, Dlaska M, Röllinghoff M, Weiss G (1997). Mechanism of suppression of macrophage nitric oxide release by IL-13. Influence of the macrophage population. J Immunol 159: 4506-4513.
4. Bogdan C, Röllinghoff M (1999). How do protozoan parasites survive inside macrophages? Parasitol Today 15: 22-28.
5. Bogdan C, Röllinghoff M, Diefenbach A (2000). Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12: 64-76.
6. Bonecini-Almeida MG, Chitale S, Boutsikakis I, Geng JY, Doo H, He SH, Ho JL (1998). Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN- γ and primed lymphocytes. J Immunol 160: 4490-4499.
7. Brandonisio O, Carelli G, Ceci L, Consenti B, Fasanella A, Puccini V (1992). Canine leishmaniasis in the Gargano Promontory (Apulia, South Italy). Eur J Epidemiol 8: 273-276.
8. Brandonisio O, Panaro MA, Lisi S, Marzio R, Acquafredda A, Fasanella A, Mitolo V (1998). Evaluation of nitric oxide production by dog and human macrophages in vitro infected with Leishmania infantum. Atti XX Congresso Nazionale della Società Italiana di Parassitologia, Roma, 17-20 giugno 1998. Parassitologia 40 (Suppl. 1): 1B.
9. 2 increases nitric oxide production in Leishmania infantum-infected human macrophages. Atti XXI Congresso Nazionale Società Itallana di Parassitologia. Legnaro (PD), 20-24 giugno 2000. Parassltologla 42 (Suppl. 1): 111.
10. Buates S, Matlashewski G (1999). Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 179:1485-1494.
11. Corradin SB, Mauël J (1991). Phagocytosis of Leishmania enhances macrophage activation by IFN-γ and lipopolysaccharides. J Immunol 146: 279-285.
12. Corradin S, Mauël J, Ransijn A, Stürzinger C, Vergères G (1999). Down-regulation of MARKS-related protein (MRP) in macrophages infected with Leishmania. J Biol Chem 274: 16782-16787.
13. D'Acquisto F, Sautebin L, luvone T, Di Rosa M, Carnuccio R (1998). Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kB activation in J774 macrophages. FEBS Lett 440:76-80.
14. Diefenbach A, Schindler H, Röllinghoff M, Yokoyama WM, Bogdan C (1999). Requirement for type 2 NO synthase for IL12 signaling in innate immunity. Science 284: 951-955.
15. Giorgio S, Linares E, Ischiropoulos H, Von-Zuben FJ, Yamada A, Augusto O (1998). In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotyrosine is not impaired during murine leishmaniasis. Infect Immun 66: 807-814.
16. Gradoni L, Scalone A, Gramiccia M, Troiani M (1996). Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS 10: 785-791.
17. Green SJ, Meltzer MS, Hibbs JB, Nacy CA (1990). Activated macrophages destroy Leishmania major amastígotes by an L-arginine-dependent killing mechanism. J Immunol 144: 278-83.
18. Harter L, Straubinger RK, Summers BA, Erb HN, Appel MJ (1999). Up-regulation of inducible nitric oxide synthase mRNA in dogs experimentally infected with Borrelia burgdorferi. Vet Immunol Immunop 67: 271-284.
19. Hibbs JB Jr, Taintor RR, Vavrin Z (1987a). Macrophage cytotoxicity: role of L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476.
20. Hibbs JB Jr, Vavrin Z, Taintor RR (1987b). L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cel's. J Immunol 138: 550-565.
21. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM (1988). Nitric oxide: A cytotoxic activated macrophages effector molecule. Biochem Bioph Res Co 157:87-94.
22. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chauduri G (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269.
23. Kallmann BA, Malzkorn R, Kolb H (1999). Exogenous nitric oxide modulates cytokine production in human leukocytes. Life Sci 65: 1787-1794.
24. Kroncke KD, Fehsel K, Kolb-Bachofen V (1998). Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147-156.
25. Liew FY (1991). Role of cytokines in killing of intracellular pathogens. Immunol Lett 30: 193-198.
26. Liew FY, Yun L, Millot S (1990). TNF-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145: 4306-4310.
27. 2 in macrophages: distinct susceptibility in murine J774 and RAW 264.7 macrophages. Prostaglandins 58: 87-101.
28. Lopez-Jaramillo P, Ruano C, Rivera J, Terán E, Salazar-lrigoyen R, Esplugues JV, Moncada S (1998). Treatment of cutaneous leishmaniasis with nitric oxide donor (letter). Lancet 351: 1176-1177.
29. MacMicking J, Xie Q-w, Nathan C (1997). Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350.
30. Martin E, Nathan C, Xie Q-w (1994). Role of Interferon regulatory factor 1 (IRF-1) in induction of nitric oxide synthase. J Exp Med 180: 977-984.
31. Mauël J, Ransijn A (1997). Leishmania spp.: Mechanisms of toxicity of nitrogen oxidation products. Exp Parasitol 87: 98-111.
32. Mauël J, Ransijn A, Buchmüller-Rouiller Y (1991). Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J Leukocyte Biol 49: 73-82.
33. Mauël J., Ransijn A., Corradin SB, Buchmuller-Rouiller Y (1995). Effect of PGE, and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α. J Leukocyte Biol 58: 217-224.
34. Milano S, Arcoleo F, Dieli M, Dagostino R, Dagostino P, Denucci G, Cillari E (1995). Prostaglandin E (2) regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49: 105-115.
35. Mossalayi MD, Arock M, Mazier D, Vincendeau P, Vouldoukis I (1999). The human immune response during cutaneous leishmaniasis: NO problem. Parasitol Today 15: 342-344.
36. Nandan D, Reiner NE (1995). Attenuation of gamma-interferoninduced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: Selective inhibition of signaling through Janus kinases and STAT1. Infect Immun 63: 4495-4500.
37. Nandan D, Lo R, Reiner NE (1999). Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 67: 4055-4063.
38. Ormerod AD, Copeland P, Hay I, Husain A, Ewen SWB (1999). The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. J Invest Dermatol 113: 392-397.
39. Oswald IP, Wynn TA, Sher A, James SL (1992). Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor-α required as costimulatory factor for Interferon γ-induced activation. Proc Natl Acad Sci USA 89: 8676- 8680.
40. Palmer RMJ, Ferrige AG, Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium- derived relaxing factor. Nature 327: 524-526.
41. Paludan SR, Ellermann-Eriksen S, Lovmand J, Mogensen SC (1999). lnterleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages. Scand J Immunol 49: 169-176.
42. Panaro MA, Fasanella A, Lisi S, Mitolo V, Andriola A, Brandonisio O (1998a). Evaluation of nitric oxide production by Leishmania infantum-infected dog macrophages. Immunopharm Immunot 20: 147-158.
43. Panaro MA, Lisi S, Mltolo V, Acquafredda A, Fasanella A, Carelli MG, Brandonisio O (1998b). Evaluation of killing, Superoxide anion and nitric oxide production by Leishmania infantuminfected dog monocytes. Cytobios 95: 151-160.
44. Panaro MA, Acquafredda A, Lisi S, Lofrumento DD, Trotta T, Satalino R, Saccia M, Mitolo V, Brandonisio O (1999). Inducible nitric oxide synthase and nitric oxide production in Leishmania infentum-infected human macrophages stimulated with interferon-γ and bacterial lipopolysaccharide. Int J Clin Lab Res 29: 122-127.
45. Panaro MA, Fasanella A, Acquafredda A, Lisi S, Mitolo V, Sisto M, Bertani F, Consenti B, Brandonisio O (2001). Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Comp Immunol Microb 24: 187-195.
46. Piedrafita D. Proudfoot L, Nikolaev AV, Xu DM, Sands W, Feng GJ, Thomas E, Brewer J, Ferguson MAJ, Alexander J, Liew FY (1999). Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 29: 235-244.
47. Proudfoot L, Nikolaev AV, Feng G-J, Wei X-Q, Ferguson MAJ, Brimacombe JS, Liew FY (1996). Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci USA 93: 10984-10989.
48. Snell JC, Chernyshev O, Gilbert DL, Colton CA (1997). Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukocyte Biol 62: 369-373.
49. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C (1996). Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
50. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF (1998). The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 66: 4690-4695.
51. Vodovotz Y, Bogdan C (1994). Control of nitric oxide synthase expression by transforming growth factor-β: implications for homeostasis. Progr Growth Factor Res 5: 341-351.
52. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD (1995). The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen. Proc Natl Acad Sci USA 92:7804-7808.
53. Vouldoukis I, Drapier JC, Nussler AK, Tselentis Y, Da Silva OA, Gentilini M, Mossalayi DM, Monjour L, Dugas B (1996). Canine visceral leishmaniasis: successful chemotherapy induces macrophages antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob Agents Ch 40: 253-256.
54. Vouldoukis I, Bécherel P, Riveros-Moreno V, Arock M, da Silva O, Debré P, Mazier D, Mossalayi MD (1997). lnterleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 27: 860-865.
55. Xie Q-w, Cho H, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.